Evaluation of Prognostic Factors for Unresectable or Recurrent Gastric Cancer Treated with Nivolumab

被引：0
|
作者：
Kenji Ishido
Satoshi Tanabe
Chikatoshi Katada
Yu Ishibashi
Gen Kitahara
Mie Onoue
Yo Kubota
Yasuaki Furue
Takuya Wada
Akinori Watanabe
Chika Kusano
机构：
[1] Kitasato University School of Medicine,Department of Gastroenterology
[2] Kitasato University School of Medicine,Research and Development Center for New Medical Frontiers
来源：
Journal of Gastrointestinal Cancer | 2023年 / 54卷
关键词：
Gastric cancer; Nivolumab; Neutrophil-to-lymphocyte ratio; Immune-related adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：485 / 491
页数：6
相关论文
共 50 条
  • [31] Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer
    Fukuchi, Minoru
    Ishiguro, Toru
    Ogata, Kyoichi
    Suzuki, Okihide
    Kumagai, Youichi
    Ishibashi, Keiichiro
    Ishida, Hideyuki
    Kuwano, Hiroyuki
    Mochiki, Erito
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (11) : 3618 - 3624
  • [32] Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer
    Minoru Fukuchi
    Toru Ishiguro
    Kyoichi Ogata
    Okihide Suzuki
    Youichi Kumagai
    Keiichiro Ishibashi
    Hideyuki Ishida
    Hiroyuki Kuwano
    Erito Mochiki
    Annals of Surgical Oncology, 2015, 22 : 3618 - 3624
  • [33] Prognostic factors in patients with unresectable pancreatic cancer
    Kadokura, Makoto
    Ishida, Takeshi
    Shimamura, Naruki
    Tatsumi, Akihisa
    Amemiya, Fumitake
    ANNALS OF ONCOLOGY, 2016, 27
  • [34] Survival and prognostic factors of unresectable pancreatic cancer
    Park, Joo Kyung
    Yoon, Yong Bum
    Kim, Yong-Tae
    Ryu, Ji Kon
    Yoon, Won Jae
    Lee, Sang Hyub
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2008, 42 (01) : 86 - 91
  • [35] Prognostic Factors in Patients With Unresectable Pancreatic Cancer
    Kadokura, Makoto
    Ishida, Yasuaki
    Tatsumi, Akihisa
    Takahashi, Ei
    Shindo, Hiroko
    Amemiya, Fumitake
    Takano, Shinichi
    Fukasawa, Mitsuharu
    Sato, Tadashi
    Enomoto, Nobuyuki
    PANCREAS, 2017, 46 (06) : 831 - 832
  • [36] Serum carbohydrate antigen 125 is a significant prognostic marker in patients with unresectable advanced or recurrent gastric cancer
    Tsutomu Namikawa
    Yasuhiro Kawanishi
    Kazune Fujisawa
    Eri Munekage
    Jun Iwabu
    Masaya Munekage
    Hiromichi Maeda
    Hiroyuki Kitagawa
    Michiya Kobayashi
    Kazuhiro Hanazaki
    Surgery Today, 2018, 48 : 388 - 394
  • [37] Serum carbohydrate antigen 125 is a significant prognostic marker in patients with unresectable advanced or recurrent gastric cancer
    Namikawa, Tsutomu
    Kawanishi, Yasuhiro
    Fujisawa, Kazune
    Munekage, Eri
    Iwabu, Jun
    Munekage, Masaya
    Maeda, Hiromichi
    Kitagawa, Hiroyuki
    Kobayashi, Michiya
    Hanazaki, Kazuhiro
    SURGERY TODAY, 2018, 48 (04) : 388 - 394
  • [38] Prognostic significance of systemic inflammatory markers in recurrent or metastatic head and neck cancer patients treated with nivolumab
    Tada, Hiroe
    Chikamatsu, Kazuaki
    CANCER RESEARCH, 2023, 83 (07)
  • [39] A case of advanced gastric cancer treated successfully with nivolumab
    Kawada, Junji
    Tamura, Shigeyuki
    Sasaki, Yo
    ANNALS OF ONCOLOGY, 2022, 33 : S529 - S529
  • [40] A Case of Long-Term Survival with Recurrent Liver Metastases from Gastric Cancer Treated with Nivolumab
    Horiuchi, Atsushi
    Akehi, Shun
    Fujiwara, Yuta
    Kawaharada, Sakura
    Anai, Takayuki
    CASE REPORTS IN ONCOLOGY, 2024, 17 (01): : 438 - 446
12345